TH1501002703A - Ingredient formula for capsules containing Sanchang, Sanyai, and Matad as ingredients. - Google Patents

Ingredient formula for capsules containing Sanchang, Sanyai, and Matad as ingredients.

Info

Publication number
TH1501002703A
TH1501002703A TH1501002703A TH1501002703A TH1501002703A TH 1501002703 A TH1501002703 A TH 1501002703A TH 1501002703 A TH1501002703 A TH 1501002703A TH 1501002703 A TH1501002703 A TH 1501002703A TH 1501002703 A TH1501002703 A TH 1501002703A
Authority
TH
Thailand
Prior art keywords
sanyai
matad
sanchang
ingredients
capsules containing
Prior art date
Application number
TH1501002703A
Other languages
Thai (th)
Other versions
TH152717A (en
Inventor
อรุณรัตน์ ฉวีราชนางสาวฑิฆัมพร ธูปเทียนรัตน์ ศาสตราจารย์
Original Assignee
มหาวิทยาลัยขอนแก่น สำนักงานกองทุนสนับสนุนการวิจัย (สกว)
Filing date
Publication date
Application filed by มหาวิทยาลัยขอนแก่น สำนักงานกองทุนสนับสนุนการวิจัย (สกว) filed Critical มหาวิทยาลัยขอนแก่น สำนักงานกองทุนสนับสนุนการวิจัย (สกว)
Publication of TH1501002703A publication Critical patent/TH1501002703A/en
Publication of TH152717A publication Critical patent/TH152717A/en

Links

TH1501002703A 2015-05-07 Ingredient formula for capsules containing Chang San Yai Matad as an ingredient. TH152717A (en)

Publications (2)

Publication Number Publication Date
TH1501002703A true TH1501002703A (en) 2016-06-03
TH152717A TH152717A (en) 2016-06-03

Family

ID=

Similar Documents

Publication Publication Date Title
IL254714A0 (en) Quinoline derivatives, and pharmaceutical compositions containing them
HK1243999A1 (en) Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use
IL247062A0 (en) Heterocyclic compounds , their preparation and compositions pharmaceutical containing them
DK3297605T3 (en) TOPIC, PHARMACEUTICAL COMPOSITIONS
BR112016023628A2 (en) pharmaceutical compositions.
CL2016002569A1 (en) Antibodies, pharmaceutical compositions and uses thereof
IL249646B (en) Platinum compounds, compositions, and uses thereof
IL250422B (en) Pyrrolidinone derivatives, and pharmaceutical compositions containing them
HK1256674A1 (en) Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof
LT3223796T (en) Pharmaceutical compositions, preparation and uses thereof
IL248785B (en) N-[1,5-dimethyl-3-oxo-(2,3-dihydro-1h-pyrazol-4-yl)]-4-methyl-isoxazole-3-carboxamide derivatives and pharmaceutical compositions comprising said derivatives
IL249308B (en) Quinoline derivatives their preparation, and pharmaceutical compositions containing them
IL258160B (en) Biaryl derivatives, pharmaceutical compositions containing same and uses thereof
BR112017013012A2 (en) indenyl compounds, pharmaceutical compositions and medical uses thereof
EP3313393A4 (en) Platinum compounds, compositions, and uses thereof
DK3383397T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRIN, TENOFOVIRDISOPROXILFUMARAT AND LAMIVUDIN
IL248773B (en) 1,6-naphthyridine-4,5-dione derivatives and pharmaceutical compositions comprising them
IL258977B (en) Pyperidyl derivatives, their preparation and pharmaceutical compositions containing them
DK3389633T3 (en) Pharmaceutical compositions comprising phenylaminopyrimidine derivative
HK1243927A1 (en) Composition containing theasapogenol derivative as active ingredient
DK3157506T3 (en) TASTE MASKED ORAL, PHARMACEUTICAL COMPOSITION
SG11201610636VA (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
EP3284743A4 (en) Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof
EP3313392A4 (en) Platinum compounds, compositions, and uses thereof
DK3290023T3 (en) PHARMACEUTICAL COMPOSITION WITH LONG-TERM RELEASE CONTAINING RIVASTIGMINE